Differential microRNA expression profiles between malignant rhabdoid tumor and epithelioid sarcoma: MiR193a-5p is suggested to downregulate SMARCB1 mRNA expression

Modern Pathology

Volumn 27, Issue 6, 2014, Pages 832-839

  Kohashi, Kenichi ^a   Yamamoto, Hidetaka ^a   Kumagai, Reiko ^a   Yamada, Yuichi ^a   Hotokebuchi, Yuka ^a   Taguchi, Tomoaki ^a   Iwamoto, Yukihide ^a   Oda, Yoshinao ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

epithelioid sarcoma; malignant rhabdoid tumor; microRNA

Indexed keywords

MICRORNA; MICRORNA 193A; MICRORNA 19A; UNCLASSIFIED DRUG; DNA BINDING PROTEIN; MESSENGER RNA; MIRN193 MICRORNA, HUMAN; NONHISTONE PROTEIN; SMARCB1 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; DOWN REGULATION; EPITHELIOID SARCOMA; FEMALE; GENE; GENE EXPRESSION PROFILING; GENE ISOLATION; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; MIDDLE AGED; MUTATION; NEWBORN; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR; SMARCB1 GENE; YOUNG ADULT; DNA MICROARRAY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; INFANT; SARCOMA; SOFT TISSUE TUMOR;

ADULT; AGED; CHROMOSOMAL PROTEINS, NON-HISTONE; DNA-BINDING PROTEINS; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; INFANT, NEWBORN; MALE; MICRORNAS; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RHABDOID TUMOR; RNA, MESSENGER; SARCOMA; SOFT TISSUE NEOPLASMS; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 84901852715     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2013.213     Document Type: Article

References (21)

1. Oda Y, Dal Cin P, Laskin WB. Epithelioid sarcoma, In: Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F(eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press: Lyon, France; 2013, pp 216-218.
2. Oda Y, Biegel JA. Extrarenal rhabdoid tumour, In: Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (eds). World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of Soft Tissue and Bone. IARC Press: Lyon, France; 2013, pp 228-229.
3. Beckwith JB, Palmer NF. Histopathology and prognosis of Wilms tumors: results from the First National Wilms' Tumor Study. Cancer 1978;41:1937-1948. (Pubitemid 8335406)
4. Oda Y, Tsuneyoshi M. Extrarenal rhabdoid tumors of soft tissue: clinicopathological and molecular genetic review and distinction from other soft-tissue sarcomas with rhabdoid features. Pathol Int 2006;56:287-295. (Pubitemid 43725396)
5. Hollmann TJ, Hornick JL. INI1-deficient tumors: diagnostic features and molecular genetics. Am J Surg Pathol 2011;35:e47-e63.
6. Kohashi K, Izumi T, Oda Y, et al. Infrequent SMARCB1/INI1 gene alteration in epithelioid sarcoma: a useful tool in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Hum Pathol 2009;40: 349-355.
7. Kohashi K, Nakatsura T, Kinoshita Y, et al. Glypican 3 expression in tumors with loss of SMARCB1/INI1 protein expression. Hum Pathol 2013;44:526-533.
8. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006;6:857-866. (Pubitemid 44629897)
9. Hisaoka M, Matsuyama A, Nagao Y, et al. Identification of altered MicroRNA expression patterns in synovial sarcoma. Genes Chromosomes Cancer 2011;50:137-145.
10. Subramanian S, Lui WO, Lee CH, et al. MicroRNA expression signature of human sarcomas. Oncogene 2008;27:2015-2026. (Pubitemid 351442735)
11. Kohashi K, Oda Y, Yamamoto H, et al. Highly aggressive behavior of malignant rhabdoid tumor: a special reference to SMARCB1/INI1 gene alterations using molecular genetic analysis including quantitative real-time PCR. J Cancer Res Clin Oncol 2007;133: 817-824. (Pubitemid 350218907)
12. Izumi T, Oda Y, Hasegawa T, et al. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor. Mod Pathol 2006;19:820-831. (Pubitemid 43780452)
13. Guidi CJ, Sands AT, Zambrowicz BP, et al. Disruption of Ini1 leads to peri-implantation lethality and tumori-genesis in mice. Mol Cell Biol 2001;21:3598-3603. (Pubitemid 32381795)
14. Wilson BG, Roberts CW. SWI/SNF nucleosome remo-dellers and cancer. Nat Rev Cancer 2011;11:481-492.
15. Kohashi K, Oda Y, Yamamoto H, et al. SMARCB1/INI1 protein expression in round cell soft tissue sarcomas associated with chromosomal translocations involving EWS: a special reference to SMARCB1/INI1 negative variant extraskeletal myxoid chondrosarcoma. Am J Surg Pathol 2008;32:1168-1174.
16. Sigauke E, Rakheja D, Maddox DL, et al. Absence of expression of SMARCB1/INI1 in malignant rhabdoid tumors of the central nervous system, kidneys and soft tissue: an immunohistochemical study with implications for diagnosis. Mod Pathol 2006;19:717-725.
17. Modena P, Lualdi E, Facchinetti F, et al. SMARCB1/INI1 tumor suppressor gene is frequently inactivated in epithelioid sarcomas. Cancer Res 2005;65:4012-4019. (Pubitemid 40775637)
18. Papp G, Changchien YC, Péterfia B, et al. SMARCB1 protein and mRNA loss is not caused by promoter and histone hypermethylation in epithelioid sarcoma. Mod Pathol 2013;26:393-403.
19. Sullivan LM, Folpe AL, Pawel BR, et al. Epithelioid sarcoma is associated with a high percentage of SMARCB1 deletions. Mod Pathol 2013;26:385-392.
20. Gougelet A, Pissaloux D, Besse A, et al. Micro-RNA profiles in osteosarcoma as a predictive tool for ifosfamide response. Int J Cancer 2011;129:680-690.
21. Yang Y, Zhou L, Lu L, et al. A novel miR-193a-5p-YY1-APC regulatory axis in human endometrioid endo-metrial adenocarcinoma. Oncogene 2012;32:3432-3442.